Raloxifene for prevention of osteoporotic fractures.
作者信息
Diehr Sabina, Mijal Sara, Nashelsky Joan
机构信息
Medical College of Wisconsin, Milwaukee 53226, USA.
出版信息
Am Fam Physician. 2005 Jul 1;72(1):132-4.
PMID:16035693
Abstract
摘要
相似文献
1
Raloxifene for prevention of osteoporotic fractures.
Am Fam Physician. 2005 Jul 1;72(1):132-4.
2
Who will benefit from treatment with selective estrogen receptor modulators (SERMs)?哪些人将从选择性雌激素受体调节剂（SERM）治疗中获益？
Best Pract Res Clin Rheumatol. 2005 Dec;19(6):975-81. doi: 10.1016/j.berh.2005.06.007.
3
[Who are the candidates for the treatment by raloxifen ?].[哪些人适合用雷洛昔芬进行治疗？]
Clin Calcium. 2004 Oct;14(10):111-3.
4
Raloxifene therapy in the reduction of fractures.雷洛昔芬治疗在降低骨折方面的作用
Am Fam Physician. 2000 Mar 1;61(5):1272, 1275, 1279-80.
5
Third-generation SERMs may face uphill battle.第三代选择性雌激素受体调节剂可能面临艰难挑战。
J Natl Cancer Inst. 2010 Nov 17;102(22):1690-2. doi: 10.1093/jnci/djq477. Epub 2010 Nov 8.
6
7
[SERM and quality of bone].[选择性雌激素受体调节剂与骨质量]
Clin Calcium. 2004 Oct;14(10):96-9.
8
[Evidence for the selective estrogen receptor modulator raloxifene--its pharmacological characteristics, efficacy and safety profiles].
Nihon Rinsho. 2009 May;67(5):960-6.
9
The science of selective estrogen receptor modulators: concept to clinical practice.选择性雌激素受体调节剂的科学：从概念到临床实践
Clin Cancer Res. 2006 Sep 1;12(17):5010-3. doi: 10.1158/1078-0432.CCR-06-1136.
10
[Osteoporosis therapy compared. More solid bones with bisphosphonates].[骨质疏松症治疗对比。双膦酸盐使骨骼更强健]
MMW Fortschr Med. 2003 Aug 7;145(31-32):55.
Zotero 插件